- Marzam's New Strategy Will Focus on Strengthening the Company's Position within Pharmaceutical Sector
- Agreement Signed for Share Redemption in Marzam
- Genomma Lab Internacional Announces Results for the First Quarter 2024
- Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call
- GENOMMA LAB INTERNACIONAL ANNOUNCES SEVENTH DIVIDEND PAYMENT
- Genomma Lab's ESG Rating Upgraded to A
More ▼
Key statistics
On Thursday, Genomma Lab Internacional SAB de CV (LABB:MEX) closed at 16.93, -4.35% below its 52-week high of 17.70, set on May 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.04 |
---|---|
High | 17.16 |
Low | 16.26 |
Bid | 16.93 |
Offer | 17.06 |
Previous close | 16.91 |
Average volume | 3.69m |
---|---|
Shares outstanding | 1.02bn |
Free float | 786.95m |
P/E (TTM) | 14.90 |
Market cap | 17.40bn MXN |
EPS (TTM) | 1.14 MXN |
Annual div (ADY) | 0.6233 MXN |
---|---|
Annual div yield (ADY) | 3.68% |
Div ex-date | Mar 21 2024 |
Div pay-date | Mar 25 2024 |
Data delayed at least 20 minutes, as of May 23 2024 20:59 BST.
More ▼